PMID- 37760716 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231003 IS - 2079-6382 (Print) IS - 2079-6382 (Electronic) IS - 2079-6382 (Linking) VI - 12 IP - 9 DP - 2023 Sep 8 TI - Acculturation and Subjective Norms Impact Non-Prescription Antibiotic Use among Hispanic Patients in the United States. LID - 10.3390/antibiotics12091419 [doi] LID - 1419 AB - Using antibiotics without medical guidance (non-prescription antibiotic use) may contribute to antimicrobial resistance. Hispanic individuals are a growing demographic group in the United States (US) with a high prevalence of non-prescription antibiotic use. We investigated the effects of acculturation and subjective norms on Hispanic individuals' intentions to use antibiotics without a prescription from the following sources: (1) markets in the United States (not legal), (2) other countries (abroad), (3) leftovers from previous prescriptions, and (4) friends/relatives. We surveyed self-identified Hispanic outpatients in eight clinics from January 2020 to June 2021 using the previously validated Short Acculturation Scale for Hispanics (SASH). Of the 263 patients surveyed, 47% reported previous non-prescription use, and 54% expressed intention to use non-prescription antibiotics if feeling sick. Individuals with lower acculturation (Spanish-speaking preferences) expressed greater intentions to use antibiotics from abroad and from any source. Individuals with more friends/relatives who obtain antibiotics abroad were over 2.5 times more likely to intend to use non-prescription antibiotics from friends/relatives (p = 0.034). Other predictors of intention to use non-prescription antibiotics included high costs of doctor visits and perceived language barriers in the clinic. Antibiotic stewardship interventions in Hispanic communities in the United States should consider the sociocultural and healthcare barriers influencing non-prescription use and promote language-concordant healthcare. FAU - Laytner, Lindsey A AU - Laytner LA AUID- ORCID: 0000-0002-3790-7090 AD - Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77098, USA. AD - Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Houston, TX 77021, USA. FAU - Olmeda, Kiara AU - Olmeda K AUID- ORCID: 0000-0001-9174-6526 AD - Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77098, USA. FAU - Salinas, Juanita AU - Salinas J AD - Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77098, USA. FAU - Alquicira, Osvaldo AU - Alquicira O AD - Tilman J. Fertitta Family College of Medicine, Houston, TX 77021, USA. FAU - Nash, Susan AU - Nash S AD - Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77098, USA. FAU - Zoorob, Roger AU - Zoorob R AUID- ORCID: 0000-0001-7311-6723 AD - Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77098, USA. FAU - Paasche-Orlow, Michael K AU - Paasche-Orlow MK AD - Department of Medicine, Tufts Medical Center, Boston, MA 02111, USA. FAU - Trautner, Barbara W AU - Trautner BW AD - Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Houston, TX 77021, USA. AD - Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA. AD - Department of Medicine, Section of Health Services Research, Baylor College of Medicine, Houston, TX 77030, USA. FAU - Grigoryan, Larissa AU - Grigoryan L AD - Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77098, USA. AD - Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Houston, TX 77021, USA. LA - eng GR - R01 HS026901/HS/AHRQ HHS/United States PT - Journal Article DEP - 20230908 PL - Switzerland TA - Antibiotics (Basel) JT - Antibiotics (Basel, Switzerland) JID - 101637404 PMC - PMC10525363 OTO - NOTNLM OT - acculturation OT - antibiotic resistance OT - antibiotic stewardship OT - non-prescription antibiotic use OT - socio-cultural factors OT - subjective norms COIS- B.W.T. reports grants or contracts from the VA Health Services Research & Development, Agency for Healthcare Research and Quality R18, Craig H. Neilson Foundation, Genentech, and Peptilogics, Inc.; payment from George Washington ID Board for a Review Course; travel support for meeting attendance from the VA Office of Research & Development and the Infectious Diseases Society of America; and an unpaid role on a DSMB for CSP #2004. L.G. reports grants or contracts from the Agency for Healthcare Research and Quality (AHRQ) R18, Craig H. Neilsen Foundation, and a research education grant (1R25AA028203-01) from the National Institute on Alcohol Abuse and Alcoholism Award. All other authors report no potential conflicts. EDAT- 2023/09/28 06:42 MHDA- 2023/09/28 06:43 PMCR- 2023/09/08 CRDT- 2023/09/28 01:08 PHST- 2023/07/28 00:00 [received] PHST- 2023/08/31 00:00 [revised] PHST- 2023/09/02 00:00 [accepted] PHST- 2023/09/28 06:43 [medline] PHST- 2023/09/28 06:42 [pubmed] PHST- 2023/09/28 01:08 [entrez] PHST- 2023/09/08 00:00 [pmc-release] AID - antibiotics12091419 [pii] AID - antibiotics-12-01419 [pii] AID - 10.3390/antibiotics12091419 [doi] PST - epublish SO - Antibiotics (Basel). 2023 Sep 8;12(9):1419. doi: 10.3390/antibiotics12091419.